ArticleArthritis research & therapy2014

Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.

Kaname Akamata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.